Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Hoyoku Nishino
Posters-Accepted Abstracts: J Clin Trials
β-Cryptoxanthin has been shown various aspects of health promoting activities; such as prevention of metabolic syndrome,
improvement of liver function, cancer prevention, prevention of osteoporosis, and so on. Cancer preventive activity of
β-cryptoxanthin is one of the important aspects. Since the incidence of liver cancer is increasing in the world, it is valuable
to develop an effective method for its prevention. We have conducted a clinical trial for liver cancer prevention using natural
carotenoids, including β-cryptoxanthin, and other food factors. Combinational use of carotenoids and myo-inositol was found to
prevent hepatocellular carcinoma development in patients with chronic viral hepatitis and cirrhosis, significantly. Although the
precise mechanism of β-cryptoxanthin on health promoting activities is not known yet, anti-oxidative activity might be important.
Further studies on action mechanism of β-cryptoxanthin should be continued.
Hoyoku Nishino has completed his PhD from Kyoto Prefectural University of Medicine. He is the Director of Cancer Control Center at Kyoto Prefectural University
of Medicine. He has published 456 papers in the field of “Preventive Medicine”.